| Literature DB >> 24507827 |
Zhixiang Xu1, Wei Yin1, Leonardo K Martinelli2, Joanna Evans3, Jinglei Chen1, Yang Yu1, Daniel J Wilson2, Valerie Mizrahi3, Chunhua Qiao4, Courtney C Aldrich5.
Abstract
The biosynthesis of pantothenate, the core of coenzyme A (CoA), has been considered an attractive target for the development of antimicrobial agents since this pathway is essential in prokaryotes, but absent in mammals. Pantothenate synthetase, encoded by the gene panC, catalyzes the final condensation of pantoic acid with β-alanine to afford pantothenate via an intermediate pantoyl adenylate. We describe the synthesis and biochemical characterization of five PanC inhibitors that mimic the intermediate pantoyl adenylate. These inhibitors are competitive inhibitors with respect to pantoic acid and possess submicromolar to micromolar inhibition constants. The observed SAR is rationalized through molecular docking studies based on the reported co-crystal structure of 1a with PanC. Finally, whole cell activity is assessed against wild-type Mtb as well as a PanC knockdown strain where PanC is depleted to less than 5% of wild-type levels.Entities:
Keywords: Adenylation; Bisubstrate inhibitor; Coenzyme A; Pantothenate synthetase; Tuberculosis
Mesh:
Substances:
Year: 2014 PMID: 24507827 PMCID: PMC4667779 DOI: 10.1016/j.bmc.2014.01.017
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641